Trials / Sponsors / Protalex, Inc.
Protalex, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP Immune Thrombocytopenia | Phase 1 / Phase 2 | 2015-11-01 |
| Terminated | PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP Immune Thrombocytopenia | Phase 1 / Phase 2 | 2015-09-01 |
| Completed | 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection Arthritis, Rheumatoid | Phase 1 / Phase 2 | 2015-02-01 |
| Completed | Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis Arthritis, Rheumatoid | Phase 1 | 2012-11-01 |
| Terminated | Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP Idiopathic Thrombocytopenic Purpura (ITP) | Phase 1 | 2007-12-01 |
| Completed | Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of PRTX-100 in Healthy Adult Volunt Healthy Volunteers | Phase 1 | 2007-06-01 |